February 17, 2026 02:40 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Actor Rajpal Yadav granted interim bail in ₹9-crore cheque bounce case | Learn AI or become redundant: Microsoft India President issues stark message | India’s wholesale inflation rises to 1.81% in January as manufacturing prices surge | 'India at forefront of AI revolution': PM Modi welcomes world leaders to Delhi summit | Rs 5,000 to women ahead of Tamil Nadu polls! Vijay slams Stalin, says: ‘take the money, blow the whistle’ | Modi congratulates Tarique Rahman as BNP clinches majority in Bangladesh polls | Bangladesh Polls: Tarique Rahman-led BNP secures 'absolute majority' with 151 seats in historic comeback | BJP MP files notice to cancel Rahul Gandhi's Lok Sabha membership, seeks life-long ban | Arrested in the morning, out by evening: Tycoon’s son walks free in Lamborghini crash case | ‘Why should you denigrate a section of society?’: Supreme Court pulls up ‘Ghooskhor Pandat’ makers
COVID-19
Normal business activities resume in Srinagar post lockdown | Image Credit: UNI

India reports over 48,000 COVID-19 cases, 1,005 deaths in 24 hours

| @indiablooms | Jul 01, 2021, at 04:29 pm

New Delhi/IBNS: In a slight increase in daily cases, India on Thursday reported 48,786 new COVID-19 infections besides registering 1,005 deaths apparently due to the virus in the last 24 hours.

In 24 hours between Wednesday and Thursday mornings, 61,588 COVID-19 patients have recovered, taking the discharge figure to 2,94,88,918.

As per the Health Ministry's data, the country's active cases have decreased to 5,23,257.

The daily recoveries have outnumbered the new infections for the 49th straight day.

The South Asian country, which has centralised its vaccination policy from Jun 21, has so far inoculated 33.57 crore people aged 18 or more.

Giving more strength to India's vaccination drive, native drug making company Zydus Cadila has applied to the country's drug regulator (DCGI) for an emergency use approval of its anti-COVID-19 vaccine, named ZyCov-D.

Four vaccines, Moderna, AstraZeneca's Indian version Covishield, indigenous Covaxin and Russia's Sputnik, have so far been approved by the country for their uses.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.